Cronos (CRON) had the highest return between 2014 and 2016 by a US stock in the Pharmaceuticals Industry, returning 564.3%.

ASSET	YEARS	% RETURN
Cronos (CRON)	2014-2016	564.34%
Aurora Cannabis (ACB)	2014-2016	278.87%
Supernus Pharmaceuticals (SUPN)	2014-2016	236.22%
ANI Pharmaceuticals (ANIP)	2014-2016	201.89%
Canopy Growth (CGC)	2014-2016	178.59%
Amphastar P (AMPH)	2014-2016	163.14%
Aclaris Therapeutics (ACRS)	2014-2016	127.3%
Corcept Therapeutics (CORT)	2014-2016	125.47%
Theravance Biopharma (TBPH)	2014-2016	116.14%
Phibro Animal Health (PAHC)	2014-2016	84.14%
Assertio Therapeutics (ASRT)	2014-2016	71.62%
Zoetis (ZTS)	2014-2016	68.63%
KING PHARMACEUTICALS (KG)	2014-2016	66.6%
Eli Lilly and (LLY)	2014-2016	57.15%
Wave Life Sciences (WVE)	2014-2016	53.37%
Prestige Brand (PBH)	2014-2016	45.49%
Johnson & Johnson (JNJ)	2014-2016	37.55%
Collegium Pharmaceutical (COLL)	2014-2016	29.75%
Merck (MRK)	2014-2016	29.75%
Avadel Pharmaceuticals (AVDL)	2014-2016	28.91%
ProPhase Labs (PRPH)	2014-2016	24.22%
CorMedix (CRMD)	2014-2016	23.39%
Titan Pharmaceuticals (TTNP)	2014-2016	21.22%
Bristol-Myers Squibb (BMY)	2014-2016	19.21%
Pfizer (PFE)	2014-2016	18.34%